Screening needs more answersBMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c2502 (Published 11 May 2010) Cite this as: BMJ 2010;340:c2502
- Jan van Bergen, STI AIDS Netherlands programme coordinator1
- 1Chlamydia Screening Implementation Programme The Netherlands, Amsterdam 1016 GB, Netherlands
Oakeshott and colleagues evaluated the effect of chlamydia screening on pelvic inflammatory disease.1 Although screening showed no significant effect, data suggest benefit for the screened group: 1.6% developed clinical disease in the screened group compared with 9.5% in the deferred group. The authors suggest that much of the pelvic inflammatory disease is incident disease and might …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial